Sharma Mani 4
4 · ASTRAZENECA PLC · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
AstraZeneca (AZN) SVP Sharma Mani Receives 1-Share Award
What Happened
- Sharma Mani, SVP, Group Controller and Head of Global Finance Services, acquired 1 share of AstraZeneca (transaction code A — award/grant) on 2026-06-08.
- The share was recorded at $179.75 (total value ~$180). The acquisition was made pursuant to the issuer's Share Incentive Plan.
Key Details
- Transaction date: 2026-06-08; reported price: $179.75; total value: ~$180.
- Footnote: Price reflects GBP134.54 converted to USD at GBP1.0000 = $1.3360 (rate published by the Fed on 2026-06-05).
- Shares owned after the transaction: not disclosed in the Form 4 filing.
- Filing date: 2026-06-16 (filed 8 days after the transaction; appears to be a late filing).
Context
- This was a small award under the company’s share incentive plan — typically part of routine compensation rather than an independent market purchase or sale. Such grants are common for executives and do not, by themselves, indicate a change in insider sentiment.
Insider Transaction Report
Form 4
Sharma Mani
See Remarks
Transactions
- Award
Ordinary Shares
[F1]2026-06-08$179.75/sh+1$180→ 19,263.466 total
Footnotes (1)
- [F1]Represents the acquisition of shares pursuant to the Issuer's Share Incentive Plan at a price of GBP134.54, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3360 on June 5, 2026 as published by the Board of Governors of the Federal Reserve System.
Signature
/s/ Mani Sharma|2026-06-16